SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
Alto Crescimento
A receita da empresa tem crescido de forma consistente nos últimos 3 anos, com média de 57.11% ano a ano.
Subavaliada
O PE mais recente da empresa é -28.10, em uma faixa percentil baixa de 3 anos.
Venda Institucional
As participações institucionais mais recentes são de 41.43M ações, uma redução de 9.37% em relação ao trimestre anterior.
Mantido por HACAX
O Super Investidor HACAX possui 150.02K ações desta empresa.